Prospective of Natural Gum Nanoparticulate Against Cardiovascular Disorders

Author:

Deep Aakash1,Rani Neeraj1,Kumar Ashok1,Nandal Rimmy1,Sharma Prabodh C.2,Sharma Arun K.3

Affiliation:

1. Department of Pharmaceutical Sciences, Chaudhary Bansi Lal University, Bhiwani-127021, Haryana, India

2. Department of Pharmaceutical Chemistry, Kurukshetra University, Kurukshetra, Haryana, India

3. Department of Pharmacology, Amity Institute of Pharmacy, Amity University, Gurugram, India

Abstract

Background: Objective: Various natural gums can be synergistically used in nanoparticulate drug delivery systems to treat cardiovascular diseases. Nanotechnology has been integrated into healthcare in terms of theranostics. In this review, we consider various natural gums that can be used for the preparation of nanoparticles and their role to treat cardiovascular disease. Methods: Nanoparticles can carry drugs at nanoscales and deliver them to the targeted sites with the desired pattern of drug release. They have specialized uptake mechanisms (e.g. - absorptive endocytosis) which improve the bioavailability of drugs. Results: By considering cardiovascular diseases at the molecular level, it is possible to modify the materials with nanotechnology and apply nano-formulations efficiently as compared with conventional preparations, due to the fact that the extracellular matrix (ECM) comprises components at the nanoscale range. The interactions of ECM components with cellular components occur at the nanoscale, therefore the nanomaterials have the potential to maintain the nanoscale properties of cells. The synthetic materials used to develop the nanoparticulate drug delivery system may cause toxicity. Conclusion: This problem can be overcome by using natural polymers. Natural gums can be used in nanoparticulate drug delivery systems as reducing and stabilizing agents and in some cases; they may directly or indirectly influence the rate of drug release and absorption from the preparation.

Publisher

Bentham Science Publishers Ltd.

Reference107 articles.

1. Hajar R.; Contribution to cardiovascular disease. Heart Views 2016,17(2),78-81

2. Liu M.; Li M.; Wang G.; Heart-targeted nanoscale drug delivery systems. J Biomed Nanotechnol 2014,10(9),2038-2062

3. Sharma A.K.; Haidarali S.; Nagaich U.; Apoptosis: A potential target site for natural bioactive agents during myocardial infarction. J Adv Pharm Technol Res 2014,4,264-284

4. Gundogdu E.; Senyigit Z.; Ilem-Ozdemir D.; Nanomedicine for the diagnosis and treatment of cardiovascular disease: Current status and future perspective. In: i Concept Press, ed. Cardiovasc Disease. USA: Concept Press. 2013,187-201

5. Hagens W.I.; Oomen A.G.; de Jong W.H.; Cassee F.R.; Sips A.J.; What do we (need to) know about the kinetic properties of nanoparticles in the body? Regul Toxicol Pharmacol 2007,49(3),217-229

Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3